TrialThe Lancet. Oncology2021

Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial.

Angela Lamarca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.